145 related articles for article (PubMed ID: 38745581)
1. Cobimetinib and Irinotecan Liposome.
Pickren EB; Waddell JA; Solimando DA
Hosp Pharm; 2016 Mar; 51(3):208-211. PubMed ID: 38745581
[TBL] [Abstract][Full Text] [Related]
2. Drug Monographs: Trabectedin and Trifluridine-Tipiracil.
Solimando DA; Waddell JA
Hosp Pharm; 2016 Feb; 51(2):120-128. PubMed ID: 38746764
[TBL] [Abstract][Full Text] [Related]
3. Pertuzumab, Trastuzumab, and Docetaxel for HER2-Positive Breast Cancer.
Cheng RM; Waddell JA; Solimando DA
Hosp Pharm; 2016 Jan; 51(1):35-38. PubMed ID: 38745714
[TBL] [Abstract][Full Text] [Related]
4. Drug Monographs: Ziv-aflibercept and Vincristine Sulfate Liposome.
Lee JN; Solimando DA; Waddell JA
Hosp Pharm; 2013 Jan; 48(1):14-22. PubMed ID: 24421416
[TBL] [Abstract][Full Text] [Related]
5. Irinotecan and Carboplatin (IC) Regimen for Small-Cell Lung Cancer and Non-Small-Cell Lung Cancer.
Rutledge MR; Waddell JA; Solimando DA
Hosp Pharm; 2014 Jul; 49(7):603-11. PubMed ID: 25477577
[TBL] [Abstract][Full Text] [Related]
6. Gefitinib and Sonidegib.
Medler CJ; Waddell JA; Solimando DA
Hosp Pharm; 2015 Nov; 50(10):868-872. PubMed ID: 27729673
[TBL] [Abstract][Full Text] [Related]
7. Dinutuximab and Panobinostat.
Chasick A; Solimando DA; Waddell JA
Hosp Pharm; 2015 Oct; 50(9):767-72. PubMed ID: 26912916
[TBL] [Abstract][Full Text] [Related]
8. Lenvatinib and Palbociclib.
Solimando DA; Waddell JA
Hosp Pharm; 2015 Jul; 50(7):578-82. PubMed ID: 26448668
[TBL] [Abstract][Full Text] [Related]
9. Blinatumomab and Pembrolizumab.
Tabor EE; Waddell JA; Solimando DA
Hosp Pharm; 2015 Apr; 50(4):269-73. PubMed ID: 26448656
[TBL] [Abstract][Full Text] [Related]
10. Nivolumab and Olaparib.
Solimando DA; Waddell JA
Hosp Pharm; 2015 May; 50(5):356-66. PubMed ID: 26405320
[TBL] [Abstract][Full Text] [Related]
11. Enzalutamide and ruxolitinib.
Hobson SA; Waddell JA; Solimando DA
Hosp Pharm; 2013 Feb; 48(2):104-7. PubMed ID: 24421446
[TBL] [Abstract][Full Text] [Related]
12. Paclitaxel and trastuzumab for breast cancer.
Lehmann T; Solimando DA; Waddell JA
Hosp Pharm; 2014 Apr; 49(4):338-44. PubMed ID: 24958939
[TBL] [Abstract][Full Text] [Related]
13. Paclitaxel, Carboplatin, and trastuzumab.
Lee J; Solimando DA; Waddell JA
Hosp Pharm; 2014 Nov; 49(10):913-9. PubMed ID: 25477563
[TBL] [Abstract][Full Text] [Related]
14. Drug Monographs: Avelumab and Ribociclib.
Waddell JA; Solimando DA
Hosp Pharm; 2017 Jul; 52(7):459-463. PubMed ID: 29276273
[TBL] [Abstract][Full Text] [Related]
15. Carboplatin and Liposomal Doxorubicin for Ovarian Cancer.
Nguyen J; Solimando DA; Waddell JA
Hosp Pharm; 2016 Jun; 51(6):442-9. PubMed ID: 27354744
[TBL] [Abstract][Full Text] [Related]
16. Cabazitaxel and Prednisone Regimen for Prostate Cancer.
Waddell JA; Solimando DA
Hosp Pharm; 2015 Jun; 50(6):460-3. PubMed ID: 26405336
[TBL] [Abstract][Full Text] [Related]
17. Alectinib, Ceritinib, Elotuzumab, and Venetoclax.
Waddell JA; Solimando DA
Hosp Pharm; 2016 Jul; 51(7):524-34. PubMed ID: 27559185
[TBL] [Abstract][Full Text] [Related]
18. Drug Monographs: Ixazomib and Necitumumab.
Lawson FE; Waddell JA; Solimando DA
Hosp Pharm; 2016 May; 51(5):362-6. PubMed ID: 27303088
[TBL] [Abstract][Full Text] [Related]
19. Drug Monographs: Daratumumab and Osimertinib.
Solimando DA; Waddell JA
Hosp Pharm; 2016 Apr; 51(4):288-92. PubMed ID: 27303075
[TBL] [Abstract][Full Text] [Related]
20. Drug monographs: belinostat and idelalisib.
Piper WL; Waddell JA; Solimando DA
Hosp Pharm; 2014 Dec; 49(11):1009-13. PubMed ID: 25673888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
